エーザイの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/01/07 | 7,342 | 7,360 | 7,245 | 7,274 | +19 | +0.3% | 847,700 |
2021/01/06 | 7,210 | 7,271 | 7,190 | 7,255 | +11 | +0.2% | 514,000 |
2021/01/05 | 7,339 | 7,347 | 7,214 | 7,244 | -52 | -0.7% | 726,600 |
2021/01/04 | 7,368 | 7,368 | 7,257 | 7,296 | -76 | -1% | 422,000 |
2020/12/30 | 7,411 | 7,439 | 7,358 | 7,372 | -36 | -0.5% | 678,500 |
2020/12/29 | 7,298 | 7,436 | 7,270 | 7,408 | +169 | +2.3% | 802,800 |
2020/12/28 | 7,230 | 7,285 | 7,176 | 7,239 | +27 | +0.4% | 560,600 |
2020/12/25 | 7,227 | 7,227 | 7,168 | 7,212 | -2 | ±0% | 567,400 |
2020/12/24 | 7,195 | 7,274 | 7,144 | 7,214 | -11 | -0.2% | 738,600 |
2020/12/23 | 7,283 | 7,290 | 7,218 | 7,225 | -65 | -0.9% | 586,600 |
2020/12/22 | 7,279 | 7,334 | 7,258 | 7,290 | -90 | -1.2% | 641,900 |
2020/12/21 | 7,398 | 7,398 | 7,294 | 7,380 | -40 | -0.5% | 851,700 |
2020/12/18 | 7,500 | 7,534 | 7,413 | 7,420 | -89 | -1.2% | 1,104,600 |
2020/12/17 | 7,548 | 7,585 | 7,509 | 7,509 | -51 | -0.7% | 543,800 |
2020/12/16 | 7,642 | 7,642 | 7,527 | 7,560 | -16 | -0.2% | 598,900 |
2020/12/15 | 7,600 | 7,610 | 7,530 | 7,576 | -74 | -1% | 735,100 |
2020/12/14 | 7,568 | 7,660 | 7,567 | 7,650 | +29 | +0.4% | 705,400 |
2020/12/11 | 7,653 | 7,730 | 7,521 | 7,621 | -81 | -1.1% | 1,314,400 |
2020/12/10 | 7,492 | 7,841 | 7,452 | 7,702 | +156 | +2.1% | 2,116,300 |
2020/12/09 | 7,482 | 7,577 | 7,481 | 7,546 | +66 | +0.9% | 1,351,700 |
2020/12/08 | 7,598 | 7,598 | 7,476 | 7,480 | -135 | -1.8% | 1,272,500 |
2020/12/07 | 7,725 | 7,740 | 7,573 | 7,615 | -62 | -0.8% | 819,200 |
2020/12/04 | 7,690 | 7,702 | 7,647 | 7,677 | -13 | -0.2% | 621,400 |
2020/12/03 | 7,749 | 7,749 | 7,631 | 7,690 | -94 | -1.2% | 1,000,000 |
2020/12/02 | 7,848 | 7,864 | 7,771 | 7,784 | -33 | -0.4% | 887,700 |
2020/12/01 | 7,888 | 7,982 | 7,801 | 7,817 | -70 | -0.9% | 916,300 |
2020/11/30 | 7,862 | 7,902 | 7,735 | 7,887 | +104 | +1.3% | 2,049,200 |
2020/11/27 | 7,816 | 7,827 | 7,746 | 7,783 | -36 | -0.5% | 1,096,600 |
2020/11/26 | 7,790 | 7,825 | 7,745 | 7,819 | +90 | +1.2% | 732,400 |
2020/11/25 | 7,847 | 7,876 | 7,721 | 7,729 | -61 | -0.8% | 969,500 |
2020/11/24 | 7,818 | 7,840 | 7,752 | 7,790 | +48 | +0.6% | 890,500 |
2020/11/20 | 7,797 | 7,797 | 7,718 | 7,742 | -56 | -0.7% | 670,100 |
2020/11/19 | 7,699 | 7,798 | 7,637 | 7,798 | +99 | +1.3% | 1,102,800 |
2020/11/18 | 7,747 | 7,786 | 7,644 | 7,699 | -12 | -0.2% | 992,900 |
2020/11/17 | 7,800 | 7,807 | 7,684 | 7,711 | -102 | -1.3% | 1,296,100 |
2020/11/16 | 7,980 | 7,986 | 7,811 | 7,813 | -170 | -2.1% | 1,457,600 |
2020/11/13 | 8,000 | 8,042 | 7,911 | 7,983 | -7 | -0.1% | 1,158,800 |
2020/11/12 | 8,010 | 8,060 | 7,919 | 7,990 | +84 | +1.1% | 1,383,300 |
2020/11/11 | 7,766 | 7,944 | 7,737 | 7,906 | +186 | +2.4% | 1,929,400 |
2020/11/10 | 7,887 | 7,899 | 7,660 | 7,720 | -99 | -1.3% | 2,813,400 |
2020/11/09 | 7,770 | 7,917 | 7,558 | 7,819 | -2,421 | -23.6% | 5,154,900 |
2020/11/06 | 10,540 | 10,900 | 10,200 | 10,240 | +365 | +3.7% | 4,587,200 |
2020/11/05 | 9,875 | 9,875 | 9,875 | 9,875 | +1,500 | +17.9% | 186,100 |
2020/11/04 | 8,330 | 8,442 | 8,194 | 8,375 | +195 | +2.4% | 782,500 |
2020/11/02 | 8,070 | 8,220 | 8,070 | 8,180 | +91 | +1.1% | 633,900 |
2020/10/30 | 8,307 | 8,379 | 8,076 | 8,089 | -276 | -3.3% | 1,124,300 |
2020/10/29 | 8,345 | 8,468 | 8,345 | 8,365 | -69 | -0.8% | 439,100 |
2020/10/28 | 8,440 | 8,488 | 8,393 | 8,434 | -24 | -0.3% | 488,000 |
2020/10/27 | 8,384 | 8,470 | 8,328 | 8,458 | +7 | +0.1% | 441,500 |
2020/10/26 | 8,439 | 8,494 | 8,390 | 8,451 | +121 | +1.5% | 449,100 |
951~
1000
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム